Table 2 Demographic data of patients with and without LIT1, AIGF2 and H19 LOI
| Â | LIT1 LOI (+) N = 12 | LIT1 LOI (--) N = 10 | P-value | IGF2 LOI (+) N = 18 | IGF2 LOI (--) N = 22 | P-value | H19 LOI(+) N = 3 | H19 LOI (--) N = 32 | P-value |
|---|---|---|---|---|---|---|---|---|---|
Gender | Â | Â | 1.000 | Â | Â | .749 | Â | Â | .708 |
Male | 9 (75%) | 8 (80%) | Â | 14 (77.8%) | 15 (68.2%) | Â | 3 (100%) | 23 (71.9%) | Â |
Female | 3 (25%) | 2 (20%) | Â | 4 (22.2%) | 7 (31.8%) | Â | 0 | 9 (28.1%) | Â |
Mean age, yr (SD) | 64.5 (12.4) | 61.3 (13.9) | 0.574 | 58.6 (12.4) | 62.7 (14.0) | .344 | 68.3 (13.4) | 59.7 (13.8) | .306 |
Family history of GC | 4 (33.3%) | 0 | 0.096 | 0 | 4 (18.2%) | .168 | 0 | 4 (12.5%) | 1.000 |
DM | 0 | 1 (10%) | 0.455 | 2 (11.1%) | 0 | .196 | 0 | 2 (6.25%) | 1.000 |
Cigarette smoking | 10 (83.3%) | 7 (70%) | 0.816 | 13 (72.2%) | 13 (59.1%) | .386 | 2 (66.7%) | 22 (68.8%) | 1.000 |
Alcohol consumption(>10 g/day) | 4 (33.3%) | 3 (30%) | 1.000 | 6 (33.3%) | 5 (22.7%) | .695 | 2 (66.7%) | 9 (28.1%) | .227 |